Vimarsana
Biggest News Aggregation in the World

Page 10 - Proactive Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Proactive Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Proactive Research Today - Breaking & Trending Today

Custodian REIT generates 'impressive' 8.5% total NAV return over the December quarter - Vimarsana News

Custodian REIT generates 'impressive' 8.5% total NAV return over the December quarter

Proactive Research analysts Richard Jeans presents his analysis on Custodian REIT generated an impressive 8.5% total NAV return over the December quarter,...

Oxford Cannabinoid Technologies targets a market estimated to be worth over £40 billion by 2027 - Vimarsana News

Oxford Cannabinoid Technologies targets a market estimated to be worth over £40 billion by 2027

Proactive Research analyst Ed Stacey presents his analysis on Oxford Cannabinoid Technologies (OCT) is a UK-based pharmaceutical company specialising in...

Poolbeg Pharma continues to deliver promised pipeline with second anti-infective licensing deal - Vimarsana News

Poolbeg Pharma continues to deliver promised pipeline with second anti-infective licensing deal

Proactive Research analyst Robin Davison presents his report on Poolbeg Pharma PLC (AIM:POLB) (Poolbeg Pharma PLC (AIM:POLB)) after the...

Mydecine Innovations: Further advancement of drugs derived from psychedelic compound psilocybin - Vimarsana News

Mydecine Innovations: Further advancement of drugs derived from psychedelic compound psilocybin

Proactive Research analyst Ed Stacey talks to Katie Pilbeam about his research on Mydecine Innovations Group which is a biotech and life...

Mydecine Innovations: Further advancement of drugs derived from psychedelic compound psilocybin - Vimarsana News

Mydecine Innovations: Further advancement of drugs derived from psychedelic compound psilocybin

Proactive Research analyst Ed Stacey talks to Katie Pilbeam about his research on Mydecine Innovations Group which is a biotech and life...